Search Results
-
Reversing a cystic fibrosis complication before birth
Giving a new cystic fibrosis medication to a pregnant woman who carries the gene for the disease was unexpectedly beneficial for her fetus, a Stanford Medicine team found.
-
DNA circles drive cancer development
Tiny circles of DNA harbor cancer-associated oncogenes and immunomodulatory genes promoting cancer development. They arise during transformation from pre-cancer to cancer, say Stanford Medicine-led team.
-
$18 million for transplant and gene-editing research
The California Institute for Regenerative Medicine has funded Stanford Medicine projects to improve kidney transplantation and advance treatment for a rare genetic disease in children.
-
Gel treatment heals blistering wounds
Researchers find that a gel tested in patients with a life-threatening blistering skin disease helps wounds heal. The gel — the first topical gene therapy — awaits FDA approval.
-
Predicting preeclampsia from urine, blood
Biological molecules in urine and gene-activity signals in blood can predict early in pregnancy which women develop preeclampsia, Stanford Medicine researchers found.
-
Viral genome packing key in replication
Disrupting a virus’s genome packaging can halt replication and jumpstart a natural immune response against subsequent exposures, a Stanford Medicine study finds.
-
Microbiologist Hugh McDevitt dies at 91
The Stanford immunologist’s research on how our immune cells recognize pathogens — and what happens when this process goes wrong — paved the way to modern immunology.
-
Diabetes drug linked to birth defects
In men, the use of metformin may affect sperm development in a way that increases birth defects in their sons, a study found.
-
‘Military police’ cells stem autoimmunity
A new study has identified a way that the immune system shoots down its own cells when their anti-viral activity threatens to become friendly fire. The finding could pave the way to new treatments for autoimmune diseases.
-
Common genetic profile linked to drug reaction
New medications help many people with inflammatory conditions and may ease severe COVID-19, but they carry risks.